Key result
Intensive BP targeting <130/80 mmHg reduces major CV events and mortality versus <140/90 mmHg.
Why the study?
The scientific community has long been divided over therapeutic blood pressure targets, particularly considering estimated overall cardiovascular risk, individual risk factors, and associated comorbidities.
Does intensive antihypertensive treatment reduce major cardiovascular events in hypertensive patients?
Population
Hypertensive patients
Comparison
Intensive antihypertensive treatment vs Standard target blood pressure (<140/90 mmHg)
Design
Review
Authors
Loading...
May refine individualized BP targets in hypertension; leaves open optimal thresholds for high-risk groups.
Does intensive antihypertensive treatment reduce major cardiovascular events in hypertensive patients?
Intensive blood pressure lowering to <130/80 mmHg, ideally achieved early with combination therapy, is recommended to reduce cardiovascular events in hypertensive patients.
Volpe et al. (2020) conducted a review in Arterial hypertension. Intensive antihypertensive treatment vs. Standard blood pressure targets (<140/90 mmHg) was evaluated. Intensive antihypertensive treatment targeting blood pressure <130/80 mmHg reduces major cardiovascular events, myocardial infarction, stroke, and mortality compared to a target of <140/90 mmHg.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: